Information about the shortage of the medicinal product Imazol Plus cream (clotrimazole, hexamidine)
08.11.2012
Medical Intertrade d.o.o., the marketing authorisation holder for the medicinal product Imazol Plus cream has informed the Agency for Medicinal Products and Medical Devices (HALMED) about the shortage of the aforementioned product. The shortage is caused by a business decision to terminate the distribution and withdrawal of marketing authorisation upon delivery of the currently available product on stock.
There are other authorised medicinal products available in Croatia with clotrimazole as active substance.
